138 related articles for article (PubMed ID: 36853852)
1. Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic nonsteroidal anti-inflammatory drugs.
Heath M; McDonald MC; Murphy DA; Shah SV; Shah S; Ding K; Riaz KM
J Cataract Refract Surg; 2023 Jul; 49(7):747-753. PubMed ID: 36853852
[TBL] [Abstract][Full Text] [Related]
2. Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic steroids.
Gill MS; Murphy DA; Dvorak JD; Shah SV; Riaz KM
J Cataract Refract Surg; 2022 Apr; 48(4):475-480. PubMed ID: 34653089
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Bucci FA; Waterbury LD
Adv Ther; 2011 Dec; 28(12):1089-95. PubMed ID: 22105509
[TBL] [Abstract][Full Text] [Related]
5. Topical NSAIDs effect on corneal sensitivity.
Singer DD; Kennedy J; Wittpenn JR
Cornea; 2015 May; 34(5):541-3. PubMed ID: 25826326
[TBL] [Abstract][Full Text] [Related]
6. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
Durrie DS; Kennard MG; Boghossian AJ
Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
[TBL] [Abstract][Full Text] [Related]
7. Cost comparison of commonly used postoperative topical ophthalmic antibiotics.
Crowell EL; Koduri VA; Groat RS; Lee DA
J Cataract Refract Surg; 2017 Oct; 43(10):1322-1327. PubMed ID: 29120716
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.
Rodrigues EB; Farah ME; Bottós JM; Bom Aggio F
Dev Ophthalmol; 2016; 55():212-20. PubMed ID: 26502088
[TBL] [Abstract][Full Text] [Related]
9. Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Heier JS; Awh CC; Busbee BG; Waterbury LD; Daniel P; Stoller GL; Cleary TS
Retina; 2009 Oct; 29(9):1310-3. PubMed ID: 19934822
[TBL] [Abstract][Full Text] [Related]
10. Comparison of analgesic effect of preoperative topical diclofenac and ketorolac on postoperative pain after photorefractive keratectomy.
Hong JP; Nam SM; Im CY; Yoon S; Kim TI; Kim EK; Seo KY
J Cataract Refract Surg; 2014 Oct; 40(10):1689-96. PubMed ID: 24968759
[TBL] [Abstract][Full Text] [Related]
11. Nepafenac: an ophthalmic nonsteroidal antiinflammatory drug for pain after cataract surgery.
Jones BM; Neville MW
Ann Pharmacother; 2013 Jun; 47(6):892-6. PubMed ID: 23715071
[TBL] [Abstract][Full Text] [Related]
12. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
Queen JH; Feldman RM; Lee DA
Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
[TBL] [Abstract][Full Text] [Related]
13. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Warren KA; Bahrani H; Fox JE
Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
[TBL] [Abstract][Full Text] [Related]
14. Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications: A Literature Review to Support Cost-effective Prescribing.
Wilson DJ; Schutte SM; Abel SR
Ann Pharmacother; 2015 Jun; 49(6):727-34. PubMed ID: 25725037
[TBL] [Abstract][Full Text] [Related]
15. Retrospective evaluation of the incidence of gastrointestinal bleeding in dogs receiving ophthalmic nonsteroidal anti-inflammatory drugs.
Van Vertloo LR; Terhaar HM; Viall AK; Allbaugh RA
Vet Ophthalmol; 2023 Nov; 26(6):560-564. PubMed ID: 37659073
[TBL] [Abstract][Full Text] [Related]
16. The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis.
Duan P; Liu Y; Li J
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):639-649. PubMed ID: 28130595
[TBL] [Abstract][Full Text] [Related]
17. VITREOUS PROSTAGLANDIN E2 CHANGES AFTER TOPICAL ADMINISTRATION OF DICLOFENAC 0.1%, INDOMETHACIN 0.5%, NEPAFENAC 0.3%, AND BROMFENAC 0.09.
Pastore MR; De Giacinto C; Cirigliano G; D'Aloisio R; Addobbati R; Agostinis C; Radillo O; Di Martino G; Di Nicola M; Cecchini P; Tognetto D
Retina; 2020 Sep; 40(9):1838-1845. PubMed ID: 31800462
[TBL] [Abstract][Full Text] [Related]
18. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Bucci FA; Waterbury LD
Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
[TBL] [Abstract][Full Text] [Related]
19. In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Walters T; Raizman M; Ernest P; Gayton J; Lehmann R
J Cataract Refract Surg; 2007 Sep; 33(9):1539-45. PubMed ID: 17720067
[TBL] [Abstract][Full Text] [Related]
20. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
Flach AJ; Dolan BJ
Trans Am Ophthalmol Soc; 2000; 98():101-5; discussion 105-7. PubMed ID: 11190013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
